Genome-wide study of early and severe childhood asthma identifies interaction between CDHR3 and GSDMB

Autor: Eliasen, Anders U., Pedersen, Casper Emil T., Rasmussen, Morten A., Wang, Ni, Soverini, Matteo, Fritz, Amelie, Stokholm, Jakob, Chawes, Bo L., Morin, Andréanne, Bork-Jensen, Jette, Grarup, Niels, Pedersen, Oluf, Hansen, Torben, Linneberg, Allan, Mortensen, Preben B., Hougaard, David M., Bybjerg-Grauholm, Jonas, Bækvad-Hansen, Marie, Mors, Ole, Nordentoft, Merete, Børglum, Anders D., Werge, Thomas, Agerbo, Esben, Söderhall, Cilla, Altman, Matthew C., Thysen, Anna H., McKennan, Chris G., Brix, Susanne, Gern, James E., Ober, Carole, Ahluwalia, Tarunveer S., Bisgaard, Hans, Pedersen, Anders G., Bønnelykke, Klaus

Publikováno v: In The Journal of Allergy and Clinical Immunology September 2022 150(3):622-630

A fast and robust method for whole genome sequencing of the Aleutian Mink Disease Virus (AMDV) genome

Autor: Hagberg, Emma E., Krarup, Anders, Fahnøe, Ulrik, Larsen, Lars E., Dam-Tuxen, Rebekka, Pedersen, Anders G.

Publikováno v: In Journal of Virological Methods August 2016 234:43-51

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Direct acting antiviral treatment of chronic hepatitis C in Denmark:factors associated with and barriers to treatment initiation

Autor: Sølund, Christina, Hallager, Sofie, Pedersen, Martin S, Fahnøe, Ulrik, Ernst, Anja, Krarup, Henrik B, Røge, Birgit T, Christensen, Peer B, Laursen, Alex L, Gerstoft, Jan, Bélard, Erika, Madsen, Lone G, Schønning, Kristian, Pedersen, Anders G, Bukh, Jens, Weis, Nina, Krarup, Henrik, Hansen, Jesper Bach, Mygind, Lone

Publikováno v: Gerstoft, J & DANHEP group 2018, ' Direct acting antiviral treatment of chronic hepatitis C in Denmark : factors associated with and barriers to treatment initiation ', Scandinavian Journal of Gastroenterology, vol. 53, no. 7, pp. 849-856 . https://doi.org/10.1080/00365521.2018.1467963
Sølund, C, Hallager, S, Pedersen, M S, Fahnøe, U, Ernst, A, Krarup, H B, Røge, B T, Christensen, P B, Laursen, A L, Gerstoft, J, Bélard, E, Madsen, L G, Schønning, K, Pedersen, A G, Bukh, J, Weis, N, DANHEP group, Krarup, H, Hansen, J B & Mygind, L 2018, ' Direct acting antiviral treatment of chronic hepatitis C in Denmark : factors associated with and barriers to treatment initiation ', Scandinavian Journal of Gastroenterology, vol. 53, no. 7, pp. 849-856 . https://doi.org/10.1080/00365521.2018.1467963
DANHEP Group 2018, ' Direct acting antiviral treatment of chronic hepatitis C in Denmark : factors associated with and barriers to treatment initiation ', Scandinavian Journal of Gastroenterology, vol. 53, no. 7, pp. 849-856 . https://doi.org/10.1080/00365521.2018.1467963

OBJECTIVES: We describe factors associated with and barriers to initiation of Direct Acting Antiviral (DAA) treatment in patients with chronic hepatitis C, who fulfill national fibrosis treatment guidelines in Denmark.MATERIALS AND METHODS: In this n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcf7af3c8f7f17887614489424bdb976
https://pure.au.dk/portal/da/publications/direct-acting-antiviral-treatment-of-chronic-hepatitis-c-in-denmark(0544a252-c7f7-4378-bce6-25219fe67f85).html